Skip to main content
SpringerLink
Log in

Simultaneous Novel BCR-ABL Gene Mutation and Increased Expression of BCR-ABL mRNA Caused Clinical Resistance to STI571 in Double—Ph-Positive Acute Biphenotypic Leukemia

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hocchaus A, Kreil S, AS Corbin, et al. Molecular and chromosomal mechanisms of resistance to imanitab (STI571) therapy.Leukemia. 2002;16:2190–2196.

    Article  CAS  Google Scholar 

  2. Gorre ME, Mohammed M, Ellwood K, et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.Science. 2001;293:8768–8780.

    Article  Google Scholar 

  3. von Bubnoff N, Schneller F, Peschel C, Duyster J. BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: a prospective study.Lancet. 2002;359:487–491.

    Article  Google Scholar 

  4. Branford S, Rudzki Z, Walsh S, et al. High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Phpositive acute lymphoblastic leukemia who develop imatinib (STI571) resistance.Blood. 2002;99:3472–3475.

    Article  PubMed  CAS  Google Scholar 

  5. Hofmann WK, Jones LC, Lemp NA, et al. Ph+ acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation.Blood. 2002;99:1860–1862.

    Article  PubMed  Google Scholar 

  6. Abo J, Inokuchi K, Dan K, et al. p53 and N-ras mutations in two new leukemia cell lines established from a patient with multilineage CD7-positive acute leukemia.Blood. 1993;82:2829–2836.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi, 113-8603, Bunkyo-ku, Tokyo, Japan

    Mitsuharu Inami, Koiti Inokuchi, Kazutaka Nakayama, Hideto Tamura & Kazuo Dan

  2. Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan

    Takashi Shimad

Authors
  1. Mitsuharu Inami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koiti Inokuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazutaka Nakayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hideto Tamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazuo Dan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takashi Shimad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Koiti Inokuchi.

About this article

Cite this article

Inami, M., Inokuchi, K., Nakayama, K. et al. Simultaneous Novel BCR-ABL Gene Mutation and Increased Expression of BCR-ABL mRNA Caused Clinical Resistance to STI571 in Double—Ph-Positive Acute Biphenotypic Leukemia. Int J Hematol 78, 173–175 (2003). https://doi.org/10.1007/BF02983390

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02983390

Keywords

Search

Navigation